Emerging Opportunity: Bluechip Bull Run
Here is the latest financial fact sheet of GIAN LIFE CARE. For more details, see the GIAN LIFE CARE quarterly results and GIAN LIFE CARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.6 |
No. of shares | m | 10.34 |
1 Week | % | -2.2 |
1 Month | % | -4.8 |
1 Year | % | -17.5 |
52 week H/L | Rs | 29.0/18.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
5-Yr Chart Click to enlarge
|
---|
GIAN LIFE CARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | 22 | 29 | 145 | ||
Low | Rs | NA | 12 | 13 | 12 | ||
Sales per share (Unadj.) | Rs | 558.0 | 16.3 | 22.2 | 15.4 | ||
Earnings per share (Unadj.) | Rs | 100.0 | 2.4 | 4.3 | 4.2 | ||
Diluted earnings per share | Rs | 0.1 | 1.1 | 2.0 | 4.2 | ||
Cash flow per share (Unadj.) | Rs | 121.0 | 2.9 | 4.9 | 4.5 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 110.0 | 16.3 | 20.5 | 13.6 | ||
Adj. book value per share | Rs | 0.1 | 7.4 | 9.3 | 13.6 | ||
Shares outstanding (eoy) | m | 0.01 | 4.70 | 4.70 | 10.34 | ||
Price / Sales ratio | x | 0 | 1.0 | 0.9 | 5.1 | ||
Avg P/E ratio | x | 0 | 7.1 | 4.9 | 18.6 | ||
P/CF ratio (eoy) | x | 0 | 5.8 | 4.3 | 17.3 | ||
Price / Book Value ratio | x | 0 | 1.0 | 1.0 | 5.8 | ||
Dividend payout | % | 0 | 0 | 0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 80 | 99 | 813 | ||
Total wages/salary | Rs m | 1 | 10 | 9 | 13 |
GIAN LIFE CARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6 | 76 | 105 | 159 | ||
Other income | Rs m | 0 | 1 | 3 | 5 | ||
Total revenues | Rs m | 6 | 77 | 107 | 164 | ||
Gross profit | Rs m | 2 | 23 | 35 | 69 | ||
Depreciation | Rs m | 0 | 3 | 3 | 3 | ||
Interest | Rs m | 0 | 6 | 7 | 13 | ||
Profit before tax | Rs m | 1 | 16 | 28 | 59 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 0 | 4 | 7 | 15 | ||
Profit after tax | Rs m | 1 | 11 | 20 | 44 | ||
Gross profit margin | % | 35.0 | 30.3 | 33.3 | 43.5 | ||
Effective tax rate | % | 26.0 | 27.7 | 26.8 | 25.3 | ||
Net profit margin | % | 18.0 | 14.7 | 19.3 | 27.4 |
GIAN LIFE CARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 34 | 41 | 60 | 104 | ||
Current liabilities | Rs m | 67 | 38 | 50 | 69 | ||
Net working cap to sales | % | -593.2 | 3.7 | 9.5 | 22.1 | ||
Current ratio | x | 0.5 | 1.1 | 1.2 | 1.5 | ||
Inventory Days | Days | 977 | 260 | 226 | 207 | ||
Debtors Days | Days | 8,656 | 75,097,860 | 717 | 407 | ||
Net fixed assets | Rs m | 44 | 83 | 95 | 126 | ||
Share capital | Rs m | 0 | 47 | 47 | 103 | ||
"Free" reserves | Rs m | 1 | 29 | 50 | 37 | ||
Net worth | Rs m | 1 | 76 | 97 | 140 | ||
Long term debt | Rs m | 10 | 8 | 6 | 19 | ||
Total assets | Rs m | 78 | 124 | 155 | 231 | ||
Interest coverage | x | 4.1 | 3.6 | 4.8 | 5.7 | ||
Debt to equity ratio | x | 8.9 | 0.1 | 0.1 | 0.1 | ||
Sales to assets ratio | x | 0.1 | 0.6 | 0.7 | 0.7 | ||
Return on assets | % | 1.8 | 14.0 | 17.7 | 24.4 | ||
Return on equity | % | 91.3 | 14.8 | 20.9 | 31.2 | ||
Return on capital | % | 16.5 | 25.8 | 33.9 | 44.7 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0 | 0 | 0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | ||
Fx inflow | Rs m | 0 | 0 | 0 | 0 | ||
Fx outflow | Rs m | 0 | 0 | 0 | 0 | ||
Net fx | Rs m | 0 | 0 | 0 | 0 |
GIAN LIFE CARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 30 | 15 | 29 | 58 | ||
From Investments | Rs m | -29 | -40 | -11 | -41 | ||
From Financial Activity | Rs m | 10 | 26 | -4 | 7 | ||
Net Cashflow | Rs m | 10 | 1 | 14 | 23 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arun Kumar Gupta | COMP SEC: Astha Chaturvedi | YEAR OF INC: 2018 | BSE CODE: 542918 | FV (Rs): 10 | DIV YIELD (%): - |
More Hospital & Healthcare Services Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare GIAN LIFE CARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.